peptisip-energy-hp-image1

Introducing Peptisip Energy HP

 

Heavy on protein, light on the gut

Peptisip Energy HP is a high energy, high protein peptide-based 200ml Oral Nutritional Supplement (ONS). Designed to improve GI tolerance and increase nutritional intake in patients with impaired GI function.

peptisip-high-energy-hp-cafe-latte

Up to 45% of patients with GI disorders are at risk of malnutrition.1,2

Peptisip Energy HP Malnutrition Graph V2

Malnutrition is state of nutrition in which a deficiency of energy, protein, and other nutrients causes adverse effects on the body's size, composition and function resulting in poorer clinical outcomes.3

Why are patients with GI disorders at higher risk of malnutrition?

Patients with GI disorders can present with several symptoms such as diarrhoea, bloating, abdominal pain and vomiting6.

If symptoms are improperly managed, this may lead to:

Management of GI symptoms leads to

Nutritional support is vital for patients with GI disorders, as emphasised in several ESPEN guidelines.4,5

Tolerance to formulations containing whole protein and fats is often poor in patients with GI disorders.6,7 

In patients with GI disorders, when absorption and digestion of nutrients is impaired, peptide-based feeds have been shown to improve tolerance.6,7

Introducing Peptisip Energy HP: heavy on protein, light on the gut 

Designed to improve GI tolerance and increase nutritional intake in patients with impaired GI function.

Peptisip Energy HP Profile 2022
* Medium chain triglycerides.
** Helps minimise electrolyte losses that occur in patients with GI intolerance symptoms.
† Helps meet Vitamin D requirements in patients with impaired GI function who are at risk of Vitamin D insufficiency and deficiency.

Peptisip Energy HP Suitability Bottle
†† Lactose level below 300mg/kg
 ‡ Certified by the Halal Food Council of Europe.
‡‡ Nutricia has Kosher approval for this product.
CLICK HERE TO SEE THE PEPTISIP ENERGY HP DATACARD

The evidence behind Peptisip Energy HP7

Patient compliance to Peptisip Energy HP was 18% higher than with the prescribed baseline* ONS7. Increased compliance led to improved nutritional intake:7

Peptisip Energy HP Energy Protein Intake
* Prior to commencing the study patients were taking a different oral nutritional supplement.
** A p-value of <0.05 is statistically significant. 

Peptisip Energy HP reduced the incidence and intensity of 7 out of 8 key GI symptoms.7

Peptisip Energy HP Symptom Improvements

† A p-value of ≤0.05 is statistically significant.

Want to see how Peptisip Energy HP performed in its clinical trial? 

Peptisip Energy HP has been studied7 in a variety of patients with complex conditions requiring a peptide-based ONS. Results from four of these patients have been collated in a series of clinical case studies, which are presented in this booklet. The case studies are intended to help educate healthcare professionals about the role of Peptisip Energy HP and offer practical guidance on its use in managing patients with GI intolerance symptoms.

Don't just take our word for it: see what Patient's had to say about Peptisip Energy HP during its clinical trial.7

Peptisip Energy HP Patient Quotes 2022

Peptisip Energy HP was well accepted by trial participants7

Peptisip Energy HP Taste, Texture, Thickness 2022

Try Peptisip for yourself: Order a free sample±

± Product can be provided to patients upon the request of a healthcare professional. They are intended for the purpose of professional evaluation only

 

  1. Meijers J.M., Schol J.M., van Bokhorst-de van der Schueren M.A., et al. (2009) Malnutrition prevalence in The Netherlands: results of the annual Dutcnational prevalence measurement of care problems. Br J Nutr., 101(3), pp. 417-23.
  2.  Russell C. and Elia M. (2012) Nutrition screening week in the UK and Republic of Ireland 2011. Hospitals care homes and mental health units [pdf]. BAPEN. Available from: nsw-2011-report.pdf (bapen.org.uk) [Accessed on : August 2021].
  3. Stratton R, Smith T, Gabe S. 2018 Managing malnutrition to improve lives and save money [pdf]. BAPEN. Available from: bapen.org.uk/pdfs/reports/mag/managingmalnutrition. pdf [Accessed: May 2022].
  4. Pironi L., Arends J., Bozzetti F., et al (2017) ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr., 36(2), pp.247-307.
  5. Forbes A., Eschere J., Herbuterne X. et al. (2017) ESPEN guidelines: Clinical nutrition in inflammatory bowel disease. Clin Nutr., 26(2), pp.321-47.
  6. Alexander D.D., Bylsma L.C., Elkayam L, et al. (2006) Nutritional and health benefits of semi elemental diets: A comprehensive summary of the literature. World J gastrointest Pharmacol Ther., 7(2), pp. 306-19.
  7. Nutricia ACBS trial, data on file 2022.
  8. Arvanitakis M., Ockenga J., et al. (2020) ESPEN guidelines: Clinical nutrition in acute and chronic pancreatitis. Clin Nutr., 39(3), pp.612-631.

All products mentioned are Foods for Special Medical Purposes for the dietary management of disease related malnutrition and must be used under medical supervision

 

Nutricia offers access to a wide range of support services and resources including:

  • • Our free Sampling Service to order product samples and have them sent to your patients' homes.
  • • A range of CPD accredited e-learning programmes.
  • • Order free paper copies of our support tools for yourself or to use with your patients.
  • • Sign up to receiving marketing communications and be the first to know about our free educational events & webinars, the latest scientific research and product updates.
Register today for free

 

Help us provide information most relevant to you

Please ensure your role and areas of interest are up to date.

Update profile
  • Nutricia Limited is a company registered in England and Wales with company number 00275552. VAT Number GB436975115
  • © 2024 Nutricia. All rights reserved.
x